7-3 and have established the rule of earlyintervene, approval for all cases and making approvalin science-based manner.
Second, we have put a lot of efforts toformulate the technical guiding principles for the R & D of the covid-19drugs and also the requirements for the safety and effectiveness. And we haveworked with R & D institutions to increase the quality and speed of R &D.
Third we put safety and effectiveness firstin the drug R & D.
并且我们确立了规则，像早期干预、对所有病例进行审批、以科学的方式进行审批的规则等等。
其次，我们付出了大量的努力，制定了《新冠肺炎药物的研发技术指导原则》以及对安全性和有效性的要求。我们还与研发机构合作，提高研发的质量和速度。
第三，我们将安全性和有效性放在药物研发的首位。
用户评论